Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid

References

• Wang JL, Ke DS, Lin MT. Heat shock pretreatment may protect against heatstroke-induced circulatory shock and cerebral ischemia by reducing oxidative stress and energy depletion. Shock 2005; 23(2)161–167
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860–867
   PubMed Web of Science ®Google Scholar
• Lee WC, Wen HC, Chang CP, Chen MY, Lin MT. Heat shock protein 72 overexpression protects against hyperthermia, circulatory shock, and cerebral ischemia during heatstroke. J Appl Physiol 2006; 100: 2073–2082
   PubMed Web of Science ®Google Scholar
• Field SB, Anderson RL. Thermotolerance: A review of observations and possible mechanisms. Natl Cancer Inst Monogr 1982; 61: 193–201
   PubMedGoogle Scholar
• Yang YL, Lin MT. Heat shock protein expression protects against cerebral ischemia and monoamine overload in rat heatstroke. Am J Physiol 1999; 276: H1961–H1967
   Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609–1623
   PubMed Web of Science ®Google Scholar
• Knight JA. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci 1997; 27: 11–25
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 2001; 7: 548–554
   PubMed Web of Science ®Google Scholar
• Alston TA, Mela L, Bright HJ. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 1977; 74: 3767–3771
   PubMed Web of Science ®Google Scholar
• Coles CJ, Edmondson DE, Singer TP. Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 1979; 254: 5161–5167
   PubMed Web of Science ®Google Scholar
• Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988; 451: 205–212
   PubMed Web of Science ®Google Scholar
• Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind R, Borrelli E, Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 2001; 21: 5110–5120
   PubMedGoogle Scholar
• Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993; 13: 4181–4192
   PubMed Web of Science ®Google Scholar
• Wullner U, Young AB, Penney JB, Beal MF. 3-Nitropropionic acid toxicity in the striatum. J Neurochem 1994; 63: 1772–1781
   PubMed Web of Science ®Google Scholar
• Hamilton BF, Gould DH. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage. Acta Neuropathol 1987; 72: 286–297
   PubMed Web of Science ®Google Scholar
• Binienda Z, Simmons C, Hussain S, Slikker W, Jr, Ali SF. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci Lett 1998; 251: 173–176
   PubMed Web of Science ®Google Scholar
• Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 1993; 60: 356–359
   PubMed Web of Science ®Google Scholar
• Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz J. B.3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1995; 65: 919–922
   PubMedGoogle Scholar
• Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995; 15: 8419–8429
   PubMed Web of Science ®Google Scholar
• Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Exp Neurol 1998; 154: 637–644
   PubMedGoogle Scholar
• Bowyer JF, Clausing P, Schmued L, Davies DL, Binienda Z, Newport GD, Scallet AC, Slikker W, Jr. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum. Brain Res 1996; 712: 221–229
   PubMedGoogle Scholar
• Ahuja M, Bishnoi M, Chopra K. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008; 244: 111–122
   PubMed Web of Science ®Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357–363
   PubMed Web of Science ®Google Scholar
• Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790–796
   PubMed Web of Science ®Google Scholar
• Halliwell B, Grootveld M, Gutteridge JM. Methods for the measurement of hydroxyl radicals in biomedical systems: Deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal 1988; 33: 59–90
   PubMedGoogle Scholar
• Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic Biol Med 1992; 13: 621–626
   PubMed Web of Science ®Google Scholar
• Loullis CC, Felten DL, Shea PA. HPLC determination of biogenic amines in discrete brain areas in food deprived rats. Pharmacol Biochem Behav 1979; 11: 89–93
   PubMed Web of Science ®Google Scholar
• Ase AR, Reader TA, Hen R, Riad M, Descarries L. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice. J Neurochem 2000; 75: 2415–2426
   PubMedGoogle Scholar
• Belay HT, Brown IR. Spatial analysis of cell death and Hsp70 induction in brain, thymus, and bone marrow of the hyperthermic rat. Cell Stress Chaperones 2003; 8: 395–404
   PubMedGoogle Scholar
• Cheng N, Maeda T, Kume T, Kaneko S, Kochiyama H, Akaike A, Goshima Y, Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res 1996; 743: 278–283
   Google Scholar
• Hattori A, Luo Y, Umegaki H, Munoz J, Roth GS. Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats. Neuroreport 1998; 9: 2569–2572
   PubMed Web of Science ®Google Scholar
• Reynolds DS, Carter RJ, Morton AJ. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 1998; 18: 10116–10127
   PubMedGoogle Scholar
• Johnson JR, Robinson BL, Ali SF, Binienda Z. Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats. Toxicol Lett 2000; 116: 113–118
   PubMedGoogle Scholar
• Burke WJ. 3,4-dihydroxyphenylacetaldehyde: A potential target for neuroprotective therapy in Parkinson's disease. Curr Drug Targets CNS Neurol Disord 2003; 2: 143–148
   PubMedGoogle Scholar
• Wallace LJ. A small dopamine permeability of storage vesicle membranes and end product inhibition of tyrosine hydroxylase are sufficient to explain changes occurring in dopamine synthesis and storage after inhibition of neuron firing. Synapse 2007; 61: 715–723
   PubMedGoogle Scholar
• Burke WJ, Li SW, Williams EA, Nonneman R, Zahm DS. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: Implications for Parkinson's disease pathogenesis. Brain Res 2003; 989: 205–213
   PubMed Web of Science ®Google Scholar
• Lord-Fontaine S, Averill-bates D. Heat shock inactivates cellular antioxidant defenses against hydrogen peroxide: Protection by glucose. Free Radic Biol 2002; 32: 752–765
   PubMed Web of Science ®Google Scholar
• Gao JP, Friedman S, Lanks KW. The role of reduced nicotinamide adenine dinucleotide phosphate in glucose and temperature-dependent doxorubicin cytotoxicity. Cancer Chemother Pharmacol 1993; 33: 191–196
   PubMedGoogle Scholar